Literature DB >> 30998992

High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.

Natasha Stephens Münch1, Hsin-Yu Fang2, Jonas Ingermann1, H Carlo Maurer3, Akanksha Anand2, Victoria Kellner2, Vincenz Sahm2, Maria Wiethaler2, Theresa Baumeister2, Frederik Wein2, Henrik Einwächter2, Florian Bolze4, Martin Klingenspor4, Dirk Haller5, Maria Kavanagh6, Joanne Lysaght6, Richard Friedman7, Andrew J Dannenberg8, Michael Pollak9, Peter R Holt10, Sureshkumar Muthupalani11, James G Fox11, Mark T Whary11, Yoomi Lee7, Tony Y Ren7, Rachael Elliot12, Rebecca Fitzgerald13, Katja Steiger14, Roland M Schmid2, Timothy C Wang7, Michael Quante15.   

Abstract

BACKGROUND & AIMS: Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC). Progression from BE to cancer is associated with obesity, possibly due to increased abdominal pressure and gastroesophageal reflux disease, although this pathogenic mechanism has not been proven. We investigated whether environmental or dietary factors associated with obesity contribute to the progression of BE to EAC in mice.
METHODS: Tg(ED-L2-IL1RN/IL1B)#Tcw mice (a model of BE, called L2-IL1B mice) were fed a chow (control) or high-fat diet (HFD) or were crossbred with mice that express human interleukin (IL) 8 (L2-IL1B/IL8 mice). Esophageal tissues were collected and analyzed for gene expression profiles and by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry. Organoids were established from BE tissue of mice and cultured with serum from lean or obese individuals or with neutrophils from L2-IL1B mice. Feces from mice were analyzed by 16s ribosomal RNA sequencing and compared to 16s sequencing data from patients with dysplasia or BE. L2-IL1B were mice raised in germ-free conditions.
RESULTS: L2-IL1B mice fed an HFD developed esophageal dysplasia and tumors more rapidly than mice fed the control diet; the speed of tumor development was independent of body weight. The acceleration of dysplasia by the HFD in the L2-IL1B mice was associated with a shift in the gut microbiota and an increased ratio of neutrophils to natural killer cells in esophageal tissues compared with mice fed a control diet. We observed similar differences in the microbiomes from patients with BE that progressed to EAC vs patients with BE that did not develop into cancer. Tissues from dysplasias of L2-IL1B mice fed the HFD contained increased levels of cytokines that are produced in response to CXCL1 (the functional mouse homolog of IL8, also called KC). Serum from obese patients caused organoids from L2-IL1B/IL8 mice to produce IL8. BE tissues from L2-IL1B mice fed the HFD and from L2-IL1B/IL8 mice contained increased numbers of myeloid cells and cells expressing Cxcr2 and Lgr5 messenger RNAs (epithelial progenitors) compared with mice fed control diets. BE tissues from L2-IL1B mice raised in germ-free housing had fewer progenitor cells and developed less dysplasia than in L2-IL1 mice raised under standard conditions; exposure of fecal microbiota from L2-IL1B mice fed the HFD to L2-IL1B mice fed the control diet accelerated tumor development.
CONCLUSIONS: In a mouse model of BE, we found that an HFD promoted dysplasia by altering the esophageal microenvironment and gut microbiome, thereby inducing inflammation and stem cell expansion, independent of obesity.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL1B; NK cells; cytokines; neutrophils

Mesh:

Substances:

Year:  2019        PMID: 30998992      PMCID: PMC6662596          DOI: 10.1053/j.gastro.2019.04.013

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  53 in total

1.  Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.

Authors:  Jose M Garcia; Andres E Splenser; Jennifer Kramer; Abeer Alsarraj; Stephanie Fitzgerald; David Ramsey; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

Review 2.  Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Authors:  Florian Rieder; Piero Biancani; Karen Harnett; Lisa Yerian; Gary W Falk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

3.  Obesity and Cancer: Insights for Clinicians.

Authors:  Pamela J Goodwin; Rowan T Chlebowski
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

4.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Authors:  Asaf Spiegel; Mary W Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B Chen; Jordan A Krall; Jasmine DeCock; Ioannis K Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D Kamm; Mikael J Pittet; David H Raulet; Robert A Weinberg
Journal:  Cancer Discov       Date:  2016-04-12       Impact factor: 39.397

5.  Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.

Authors:  Julie Catusse; Anne Liotard; Bruno Loillier; Didier Pruneau; Jean-Luc Paquet
Journal:  Biochem Pharmacol       Date:  2003-03-01       Impact factor: 5.858

6.  Metabolic syndrome and the risk of Barrett's oesophagus in white males.

Authors:  A P Thrift; J Hilal; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2015-03-20       Impact factor: 8.171

7.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  Opportunities for Preventing Esophageal Adenocarcinoma.

Authors:  John Maret-Ouda; Hashem B El-Serag; Jesper Lagergren
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-13

9.  Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

Authors:  Catherine Duggan; Lynn Onstad; Sheetal Hardikar; Patricia L Blount; Brian J Reid; Thomas L Vaughan
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-01       Impact factor: 11.382

10.  High-fat diet enhances stemness and tumorigenicity of intestinal progenitors.

Authors:  Semir Beyaz; Miyeko D Mana; Jatin Roper; Dmitriy Kedrin; Assieh Saadatpour; Sue-Jean Hong; Khristian E Bauer-Rowe; Michael E Xifaras; Adam Akkad; Erika Arias; Luca Pinello; Yarden Katz; Shweta Shinagare; Monther Abu-Remaileh; Maria M Mihaylova; Dudley W Lamming; Rizkullah Dogum; Guoji Guo; George W Bell; Martin Selig; G Petur Nielsen; Nitin Gupta; Cristina R Ferrone; Vikram Deshpande; Guo-Cheng Yuan; Stuart H Orkin; David M Sabatini; Ömer H Yilmaz
Journal:  Nature       Date:  2016-03-03       Impact factor: 49.962

View more
  38 in total

Review 1.  Microbiome of the Aerodigestive Tract in Health and Esophageal Disease.

Authors:  Aws Hasan; Laith K Hasan; Bernd Schnabl; Madeline Greytak; Rena Yadlapati
Journal:  Dig Dis Sci       Date:  2020-11-24       Impact factor: 3.199

Review 2.  Associations of the microbiome and esophageal disease.

Authors:  Ikenna Okereke; Catherine Hamilton; Alison Wenholz; Vikram Jala; Thao Giang; Sandy Reynolds; Aaron Miller; Richard Pyles
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 3.  Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's Esophagus.

Authors:  Nicola F Frei; Matthew D Stachler
Journal:  Visc Med       Date:  2022-02-02

4.  Deciphering the Immune Complexity in Esophageal Adenocarcinoma and Pre-Cancerous Lesions With Sequential Multiplex Immunohistochemistry and Sparse Subspace Clustering Approach.

Authors:  Srinand Sundaram; Eun Na Kim; Georgina M Jones; Shamilene Sivagnanam; Monika Tripathi; Ahmad Miremadi; Massimiliano Di Pietro; Lisa M Coussens; Rebecca C Fitzgerald; Young Hwan Chang; Lizhe Zhuang
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

5.  Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.

Authors:  Bettina Kunze; Frederik Wein; Hsin-Yu Fang; Akanksha Anand; Theresa Baumeister; Julia Strangmann; Sophie Gerland; Jonas Ingermann; Natasha Stephens Münch; Maria Wiethaler; Vincenz Sahm; Ana Hidalgo-Sastre; Sebastian Lange; Charles J Lightdale; Aqiba Bokhari; Gary W Falk; Richard A Friedman; Gregory G Ginsberg; Prasad G Iyer; Zhezhen Jin; Hiroshi Nakagawa; Carrie J Shawber; TheAnh Nguyen; William J Raab; Piero Dalerba; Anil K Rustgi; Antonia R Sepulveda; Kenneth K Wang; Roland M Schmid; Timothy C Wang; Julian A Abrams; Michael Quante
Journal:  Gastroenterology       Date:  2020-04-20       Impact factor: 22.682

6.  Identification of TLR2 Signalling Mechanisms Which Contribute to Barrett's and Oesophageal Adenocarcinoma Disease Progression.

Authors:  Ewelina Flis; Gillian Barber; Ciara Nulty; Brian Keogh; Peter McGuirk; Akanksha Anand; Jacintha O'Sullivan; Michael Quante; Emma M Creagh
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

Review 7.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

Review 8.  Neutrophil dynamics in the tumor microenvironment.

Authors:  Amanda J McFarlane; Frédéric Fercoq; Seth B Coffelt; Leo M Carlin
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 9.  Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome.

Authors:  Joshua Bilello; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-05-29

Review 10.  Stem cells and origins of cancer in the upper gastrointestinal tract.

Authors:  Yoku Hayakawa; Hiroshi Nakagawa; Anil K Rustgi; Jianwen Que; Timothy C Wang
Journal:  Cell Stem Cell       Date:  2021-06-14       Impact factor: 25.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.